Document:

<PAGE>   1
                                                                   EXHIBIT 10.12

                              EMPLOYMENT AGREEMENT

         THIS EMPLOYMENT AGREEMENT (the "Agreement") is dated as of April 11,
2000, between ELECTRONIC MEDICAL DISTRIBUTION, INC. d/b/a EMD.COM, a Delaware
corporation (the "Company"), and GEOFFREY L. FAUX (the "Executive").

         1.       Employment. The Company hereby agrees to employ the Executive,
and the Executive hereby agrees to be employed by the Company, on the terms and
conditions set forth herein.

         2.       Term.

                  (a)      The "Initial Term" of the employment of the Executive
         by the Company as provided in Section 1 will commence on April 11, 2000
         (the "Effective Date") and will terminate at 11:59 p.m. on April 11,
         2003 (the "Expiration Date") unless extended or sooner terminated as
         hereinafter provided (such period, the "Employment Period").

                  (b)      The "Employment Period" may be extended beyond the
         Initial Term by the mutual agreement of the parties in writing at least
         ninety (90) days prior to the end of the Initial Term (the "Extended
         Term").

                  (c       ) The "Business" of the Company shall be medical
         e-commerce online and provide physicians with internet medication
         management solutions.

         3.       Position, Duties and Responsibilities.

                  (a)      Position. The Executive hereby agrees to serve as
         President of eMD.com reporting to the Board of Directors of the Company
         ("Board") and to the Chief Executive Officer of the Company ("CEO").
         The Executive will observe on the Board for six (6) months and then
         Executive will be reviewed at the end of said period by the Board of
         Directors to become a member.

                  Duties/Goals/Objectives:

                  -        Review current company structure and
                           design/form/develop new infrastructure structure to
                           meet the company business plan needs for the next 24
                           months.
                  -        Review and complete for years 1, 2 and 3 Business
                           Plans and financial projections/forecasts.
                  -        Review and implement reporting procedures and
                           accountability.
                  -        Provide broader coverage of the company on Wall
                           Street.
                  -        Assist in raising capital for eMD and make
                           preparations for taking the company public.
                  -        Set financial and performance goals and revenue
                           objectives including timetables.
                  -        Provide weekly report to Tim Moses.

                  (b)      Place of Employment. During the term of this
         Agreement, the Company's headquarters shall be located in the greater
         Atlanta, Georgia area.

                  (c)      Other Activities. Except with the prior written
         approval of the Board (which the Board may grant or withhold in its
         sole and absolute discretion), the Executive, during the Employment
         Period, will not (i) accept any other employment, or (ii) engage,
         directly or indirectly, in any other business activity (whether or not
         pursued for pecuniary advantage) that is or may be competitive with or
         that might place him in a competing position to, that of the Company or
         any of its affiliates. Notwithstanding the foregoing, the Company
         agrees that the Executive (or affiliates of the Executive) shall be
         permitted: (i) to make any passive personal investments that are not in
         a business activity that is directly or indirectly competitive with the
         Company (ii) to participate in industry organizations, (iii) with the
         consent of the Board of Directors of the Company, to be a member of
         Boards of Directors of other entities which do not directly compete
         with the Company, and (iv) to participate in charitable or educational
         activities.

                  (d)      Present Outside Activities. Executive shall disclose
         to the Board and to the CEO all outside activities in which he is
         involved and any apparent conflict of interest prior to the execution
         of this Agreement.

<PAGE>   2
         4.       Compensation and Related Matters.

                  (a)      Salary and Bonus. During the Employment Period, the
         Company shall pay the Executive a salary of two hundred fifty thousand
         dollars ($250,000.00) annually (the "Salary"). The Executive shall also
         be eligible for bonuses of 50% of the Executive's salary as may be
         determined in the sole discretion of the Board of Directors and/or the
         CEO. All Salary and bonuses to be paid consistent with the standard
         payroll practices of the Company (e.g., timing of payments and standard
         employee deductions, such as income tax withholdings, social security,
         etc.).

                  (b)      Stock Options.

                           (1)      In addition to the Salary, the Executive
                                    shall be entitled to receive a stock option
                                    granted in accordance with the terms and
                                    conditions set forth in the Company's stock
                                    option plan and the stock option agreement.
                                    The amount of shares granted under the stock
                                    option shall be 900,000 vested over three
                                    years in equal annual amounts at a strike
                                    price of $4.67.

                           (2)      Stock option break-up fee. If both parties
                                    agree that the Executive's employment with
                                    Company terminates prior to April 11, 2001,
                                    then Company will give 50,000 options at a
                                    strike price of $4.67.

                  (c)      Vacation. During the Employment Period Executive
         shall be entitled to 20 days of vacation during each calendar year and
         shall not be cumulative, unless and until the Company changes its
         policy toward accumulation of vacation days for other employees of the
         Company in which case Executive's vacation days shall follow such
         policy of the Company. Unless and until such policy change at no time
         shall Executive be entitled to receive more than 20 days of vacation.

                  (d)      Business Expenses. The Company will reimburse the
         Executive for reasonable bona fide business expenses incurred on behalf
         of the Company in the ordinary course of business, provided, however,
         that the expense is otherwise deductible by the Company as an ordinary
         and necessary business expense for federal income tax purposes.

                  (e)      Relocation Expenses: Total estimate cost for
         relocation $50,000 +/- 10% either way. This amount includes
         compensation of relocation from current property to the Atlanta,
         Georgia area home. Reimbursement of real estate commissions resulting
         from sale of current home and closing costs pursuant to the purchase of
         the Atlanta area home. Costs that are not included would be the Brokers
         costs. Reimbursable costs include moving of personal items, mover and
         travel expenses. The Executive will also receive temporary living
         expenses of $8,000.

                  (f)      Other Benefits. The Executive shall generally be
         entitled to participate in or receive health, long-term disability
         insurance, and similar benefits as the Company provides from time to
         time to its executives. The Executive shall cooperate with the issuance
         of a key man term life insurance policy for the benefit of the Company,
         if so requested by the Company.

                  (g)      Withholding. All salary, bonus payments, stock option
         exercises, benefit payments and other payments due to Executive under
         this Agreement shall be paid in a manner consistent with the standard
         payroll practices of the Company. The Company may withhold from any
         payment any required taxes or other governmental withholdings,
         insurance or benefit payments and similar items.

                  (h) CHANGE OF CONTROL. IN THE EVENT THERE IS A CHANGE OF
CONTROL OF THE COMPANY, THEN THIS OPTION SHALL NOT TERMINATE BUT RATHER OPTIONEE
SHALL HAVE THE IMMEDIATE RIGHT TO EXERCISE THIS OPTION WITH RESPECT TO ALL
SHARES GRANTED PURSUANT TO THIS OPTION AT ANY TIME, NOTWITHSTANDING THE
PROVISION OF SECTION 6 HEREOF, PROVIDED, HOWEVER, THAT SHOULD THE CHANGE OF
CONTROL RESULT IN THE TERMINATION OF THIS OPTION WITHOUT THE SIMULTANEOUS
CONVERSION OF THIS OPTION INTO OPTIONS TO PURCHASE LIKE STOCK OF THE COMPANY, OR
A CORPORATION ACQUIRING OR SUCCEEDING TO THE RIGHTS OF THE COMPANY IN SUCH
CHANGE OF CONTROL, UPON TERMS SUBSTANTIALLY SIMILAR TO THOSE DESCRIBED HEREIN,
THEN OPTIONEE SHALL HAVE THE IMMEDIATE RIGHT UPON SUCH CHANGE OF CONTROL TO
EXERCISE THIS OPTION WITH RESPECT TO ALL SHARES GRANTED PURSUANT TO THIS OPTION
AT ANY TIME, REGARDLESS OF WHETHER OPTIONEE'S EMPLOYMENT WITH THE COMPANY HAS
TERMINATED.

         FOR PURPOSES OF THIS SECTION, "CHANGE OF CONTROL" OF THE COMPANY SHALL
BE DEEMED TO HAVE OCCURRED IF (I) A TENDER OFFER SHALL BE MADE AND CONSUMMATED
FOR THE OWNERSHIP OF 50% OR MORE OF THE OUTSTANDING VOTING SECURITIES OF THE
COMPANY, (II) THE COMPANY SHALL SELL SUBSTANTIALLY ALL OF ITS ASSETS TO ANOTHER
CORPORATION THAT IS NOT A WHOLLY OWNED SUBSIDIARY, (III) A PERSON, WITHIN THE
MEANING OF SECTION 3 (A) 9 OR OF SECTION 13 (A) (3) (AS IN EFFECT ON THE DATE
HEREOF) OF THE SECURITIES EXCHANGE ACT OF 1934, SHALL ACQUIRE 50% OR MORE OF THE
OUTSTANDING VOTING SECURITIES OF THE COMPANY (WHETHER DIRECTLY, INDIRECTLY,
BENEFICIALLY OR OF RECORD), OR (IV) THERE SHALL BE A CHANGE WITHIN THE PERIOD
BEGINNING WITH THE FIRST DAY AFTER ANY ANNUAL MEETING OF STOCKHOLDERS OF THE
COMPANY, OF MORE THAN TWO-THIRDS OF ITS MEMBERS OF THE BOARD OF DIRECTORS OF THE
COMPANY. FOR
<PAGE>   3

PURPOSES HEREOF, OWNERSHIP OF VOTING SECURITIES SHALL TAKE INTO ACCOUNT AND
SHALL INCLUDE OWNERSHIP AS DETERMINED BY APPLYING THE PROVISIONS OF RULE
13D-3(1)(I) (AS IN EFFECT ON THE DATE HEREOF) PURSUANT TO THE SECURITIES
EXCHANGE ACT OF 1934.

         5.       Termination or Resignation.

                  (a)      Termination. The Executive's employment hereunder
         shall be, or may be, as the case may be, terminated and shall
         constitute a "Termination" under the following circumstances:

                           (i)      Death. The Executive's employment hereunder
         shall terminate upon his death.

                           (ii)     Disability. The Executive's employment
         hereunder shall terminate on the Executive's physical or mental
         disability or infirmity which, in the opinion of a competent physician
         selected by the Board, renders the Executive unable to perform his
         duties under this Agreement for more than 30 days during any 120-day
         period.

                           (iii)    With Cause. The Company may terminate the
         Executive's employment hereunder for Cause. "Cause" shall mean (a)
         Executive's material breach of any of the terms of this Agreement, (b)
         Executive's conviction of a crime involving moral turpitude or
         constituting a felony under the laws of any state, the District of
         Columbia or of the United States, (c) Executive's repeated failure or
         refusal to follow the directives of the Board or the CEO; (d)
         Executive's inappropriate business conduct that is directly related to
         Executive's activities on behalf of the Company that may cause material
         harm to the business interests of the Company; or (e) Executive's
         inability to practice medicine for any reason, including, but not
         limited to, the loss of Executive's professional license to practice
         medicine.

                           (iv)     By the Company for Any Other Reason. The
         Company may terminate the Executive's employment hereunder at any time
         for any reason other than the Executive's Death or Disability or for
         Cause.

                           (v)      Resignation of Executive. The Executive may
         voluntarily resign his position and terminate his employment and Salary
         with the Company at any time, with or without cause, by delivery of a
         written notice of resignation to the Company (the "Notice of
         Resignation"). The Notice of Resignation shall set forth the date such
         resignation shall become effective (the "Date of Resignation"), which
         date shall, in any event, be at least thirty (30) days and no more than
         sixty (60) days from the date the Notice of Resignation is delivered to
         the Company. At its option, the Company may reduce such notice period
         to any length, upon written notice to the Executive.

                  (b)      Notice of Termination by Company. Any termination of
         the Executive's employment by the Company shall be communicated by
         written Notice of Termination to the Executive. For purposes of this
         Agreement, a "Notice of Termination" shall mean a notice that shall
         indicate the specific termination provision in this Agreement relied
         upon and shall set forth, if applicable, in reasonable detail the facts
         and circumstances claimed to provide a basis for termination of the
         Executive's employment under the provision so indicated. "Date of
         Termination" shall mean (i) if the Executive's employment is terminated
         by his death, the date of his death, (ii) if the Executive's employment
         is terminated by reason of his disability, the date of the opinion of
         the physician referred to in Section 5(a)(ii), above, (iii) if the
         Executive's employment is terminated by the Company for Cause pursuant
         to subsection 5(a)(iii) above or without Cause pursuant to subsection
         5(a)(iv) above, the date specified in the Notice of Termination and
         (iv) if the Executive voluntarily resigns pursuant to subsection
         5(a)(v) above, the date of the Notice of Resignation.
<PAGE>   4

                  (c)      Terminability of Employment. Notwithstanding the Term
         of this Agreement and the annual salary to be paid to the Executive
         during his employment with the Company, nothing in this Agreement
         should be construed as to confer any right of the Executive to be
         employed by the Company for a fixed or definite term. Subject to
         Section 6 hereof, the Executive hereby agrees that the Company may
         dismiss him under subsection 5(a) hereof. The Executive's employment
         with the Company may be terminated by the Company at any time by
         delivery of a Notice of Termination to the Executive, for any reason,
         with or without cause, without liability except with respect to the
         payments provided for by Section 6.

                  (d)      Termination Obligations. In exchange for the Company
         entering into the Agreement and payment of the Severance Payments
         provided for in Sections 6(b) and 6(e) herein, the Executive agrees
         that, at the time of his resignation or termination from the Company:

                           (i)      The Executive will promptly return to the
                                    Company all personal property, both tangible
                                    and intangible, furnished to or prepared by
                                    the Executive in the course of or incident
                                    to his employment, the Executive hereby
                                    acknowledging and agreeing that such
                                    property belongs to the Company, such that
                                    following termination the Executive will not
                                    retain any written or other tangible
                                    material containing any proprietary
                                    information of the Company. "Personal
                                    property" includes, without limitation, all
                                    computers, cellular phones, company credit
                                    cards, access keys, books, manuals, records,
                                    reports, notes, contracts, lists and other
                                    documents or materials, or copies thereof
                                    (including computer files), and all other
                                    proprietary information relating to the
                                    business of the Company.

                            (ii)    The Executive will tender his resignation
                                    from all offices and directorships then
                                    held with the Company; Executive, however,
                                    shall not be required to tender his
                                    resignation from the Board of Directors of
                                    the Company.

                            (iii)   The Executive will execute a release
                                    acceptable to the Company of all liability
                                    of the Company, and its directors,
                                    officers, shareholders, employees, agents
                                    and attorneys, to the Executive in
                                    connection with or arising out of his
                                    employment with the Company, except with
                                    respect to any Severance Payments under
                                    Sections 6(b) or 6(d) which may be payable
                                    to him under the terms of the Agreement.

                            (iv)    The representations and warranties
                                    contained herein and the Executive's
                                    obligations under Sections 5(d), 7, 8, 9
                                    and 15 through 18 shall survive termination
                                    of the Employment Period and the expiration
                                    of this Agreement.

         6.       Compensation Upon Termination. Upon the occurrence of any of
the events described Section 5(a)(i) through 5(a)(v) of this Agreement, the
Executive shall be entitled, unless otherwise provided herein, to the following
remuneration in respect of such Termination (the "Severance Payments") for the
period of time specified therein (the "Severance Period"):

                  (a)      Death. If the Executive's employment shall be
         terminated pursuant to Section 5(a)(i), the Company shall pay the
         Executive's personal representative his Salary payable pursuant to
         Section 4(a) through the Date of Termination. At the

<PAGE>   5

Executive's own expense, the Executive's dependents shall also be entitled to
any continuation of health insurance coverage rights under any applicable law.

         (b)      Disability. If the Executive's employment shall be terminated
by reason of disability pursuant to Section 5(a)(ii), the Executive shall
receive his Salary payable pursuant to Section 4(a) up to the Date of
Termination and for 30 days thereafter; provided that payments so made to the
Executive during the disability shall be reduced by the sum of the amounts, if
any, payable to the Executive at or prior to the time of any such payment under
any disability benefit plan of the Company. At the Executive's own expense, the
Executive and his dependents shall also be entitled to any continuation of
health insurance coverage rights under any applicable law.

         (c)      Cause. If the Executive's employment shall be terminated for
Cause pursuant to Section 5(a)(iii) hereof, the Company shall pay the Executive
his Salary then payable pursuant to Section 4(a) through the Date of
Termination. At the Executive's own expense, the Executive and his dependents
shall also be entitled to any continuation of health insurance coverage rights
under any applicable law.

         (d)      Voluntary Resignation. If the Executive terminates his
employment with the Company pursuant to Section 5(a)(v) hereof, the Company
shall have no obligation to compensate the Executive following the Date of
Resignation, except for the payment of accrued and unpaid salary pursuant to
Section 4(a) through the Date of Resignation. In any event, at the Executive's
own expense, the Executive and his dependents shall be entitled to any
continuation of health insurance coverage rights under any applicable law.

         (e)      Termination Without Cause by Company. If the Company
terminates Executive's employment with the Company pursuant to Section 5(a)(iv),
the Company shall continue to pay to Executive all Salary payable pursuant to
Section 4(a), as Severance Payments through a period ending twelve (12) months
following the Date of Termination provided the Executive was employed for twelve
(12) months previous to termination. In addition for the period that the
Severance Payments are being paid to the Executive, the Executive and the
Executive's family shall be entitled to receive welfare plan benefits (other
than continued group long-term disability coverage) generally available to
executives of the Company with comparable responsibilities or positions at the
same cost to the Executive as is charged to such similar executives from time to
time for comparable coverage. The Company shall have no other obligation to
compensate the Executive following the Date of Termination except as provided
herein.

         (f)      Any Severance Payments made pursuant to this Section 6 shall
be payable in accordance with the Company's regular payroll practices. The
obligation of the Company to make the Severance Payments to the Executive is
expressly conditioned upon the Executive complying and continuing to comply with
his obligations and covenants under Sections 5(d), 7 and 8 of this Agreement
following termination of his employment with the Company.

         (g)      Any Severance payments will be effective after the Executive
has completed one year of service to the Company. If the Executive does not
complete one year of service he is not entitled to any Severance.

7.       Confidentiality and Non-Solicitation Covenants.

         (a)      Confidentiality. In addition to the agreements set forth in
Section 5(e), the Executive hereby agrees that the Executive will not, during
the Employment Period or at any time thereafter directly or indirectly disclose
or make available to any person, firm, corporation, association or other entity
for any reason or purpose whatsoever, any Confidential Information (as defined
below). The Executive agrees that, upon Termination of his employment with the
Company, all Confidential Information in his possession that is in written or
other tangible form (together with all copies or duplicates thereof, including
computer files) shall be returned to the Company and shall not be retained by
the Executive or furnished to any third party, in any form except as provided
herein; provided, however, that the Executive shall not be obligated to treat as
confidential, or return to the Company copies of any Confidential Information
that (i) was publicly known at the time of disclosure to the Executive, (ii)
becomes publicly known or available thereafter, but prior to the Date of
Termination, other than by any means in violation of this Agreement or any other
duty owed to the Company by any person or entity or (iii) is lawfully disclosed
to the Executive by a third party. As used in this Agreement the term
"Confidential Information" means: information disclosed to the Executive or
known by the Executive as a consequence of or through his relationship with the
Company, about the

                                      -24-
<PAGE>   6

         directors, officers, shareholders, customers, employees, investors,
         business methods, public relations methods, organization, procedures or
         finances, including, without limitation, information of or relating to
         shareholder, customer or investor lists of the Company and any
         affiliate.

                  (b)      Non-Solicitation. In addition, the Executive hereby
         agrees that during the Employment Period, and for a period of one (1)
         year thereafter, regardless of the reason or circumstances of
         Termination of employment with the Company, the Executive will not,
         either on his own account or jointly with or as a manager, agent,
         officer, employee, consultant, partner, joint venturer, owner or
         shareholder or otherwise on behalf of any other person, firm or
         corporation, (i) carry on or be engaged or interested directly or
         indirectly in, or solicit, the sale or provision of services or the
         development or marketing of services as offered by the Company to its
         customers at the Date of Termination, (ii) endeavor directly or
         indirectly to canvas or solicit in competition with Company or to
         interfere with the supply of orders for goods or services from or by
         any person, firm or corporation which during the Employment Period has
         been or is a supplier of goods or services to Company or become an
         investor in the Company or (iii) directly or indirectly solicit or
         attempt to solicit away from Company any of its officers or employees
         or offer employment to any person who, at any time during the six (6)
         months immediately preceding the Date of Termination, is or was an
         officer or employee of Company.

         8.       Covenant Not to Compete. The Executive agrees that during the
Employment Period he will devote full-time to the business of the Company and
not engage in any type of business which engages in the medical internet, online
pharmacy and information services or any other related businesses, including but
not limited to all aspects of the Business. Subject to such full-time
requirement and the restrictions set forth below in this Section 8 and Section
3(c) above, the Executive shall be permitted to continue his existing business
investments and activities and may pursue additional business investments;
provided that the Executive may not serve as a director or officer of any public
company resulting from such business investments if such public company is in
competition with the Company. The Executive agrees that, from the end of the
Employment Period through a one (1) year period thereafter, he shall not, within
the Protected Territory (as defined hereinafter), (i) invest in, manage, consult
or participate in any way in any other business in competition with the Business
(in either an active or passive manner), (ii) participate in or advise any
business which has business activities similar to the Business are a relevant
business segment, or (iii) act for or on behalf of any business that intends to
enter or participate in any business which has any business activities similar
to the Business, in each case unless the independent members of the Company's
Board determines that such action is in the best interests of the Company.
Notwithstanding the foregoing, the Executive may purchase stock as a stockholder
in any publicly traded company, including any company which is involved in the
development or operation of a medical internet site in the Protected Territory;
provided that the Executive does not own (together or separately or through his
affiliates) more than five percent (5%) of any company (other than the Company)
engaged in a business which is competitive with the Business of the Company
within the Protected Territory. In addition, the Executive shall not invest
(directly or indirectly) in any competitive business operating within the
Protected Territory unless the independent members of the Company's Board
determines that such an investment is in the best interests of the Company. For
purposes of this Agreement, the "Protected Territory" shall mean that area
within a one hundred (100) mile radius of the principal offices of the Company
at the Date of Termination.

Indemnity on Non-Compete. Executive hereby indemnifies the Company for any and
all liabilities that should arise from Executive's prior employments and
consulting, including necessary legal costs for Company to defend such matters.

         9.       Injunctive Relief and Enforcement. In the event of breach by
either party of the terms of Sections 5, 6, 7 or 8, if the non-breaching party
believes it is suffering irreparable injury, then the non-breaching party shall
be entitled to institute legal proceedings to enforce the specific performance
of this Agreement by the breaching party and to enjoin the breaching party from
any further violation of the Agreement and to exercise such remedies
cumulatively or in conjunction with all other rights and remedies provided by
law and not otherwise limited by this Agreement. The parties acknowledge,
however, that the remedies at law for any breach of the provisions of Sections
5, 6, 7 or 8 may be inadequate. In addition, in the event the covenants set
forth in Sections 5(e), 7 or 8 shall be determined by any court of competent
jurisdiction to be unenforceable by reason of extending for too great a period
of time or over too great a geographical area, by reason of being too
restrictive or expansive, or by constituting an unlawful restraint of trade in
any other respect, each such covenant shall be interpreted to extend over the
maximum period of time and over a maximum geographical area for which it may be
enforceable, and to the maximum extent in all other respects as to which it may
be enforceable, and enforced as so interpreted, all as determined by such court
in such action.

         10.      Notice. For the purposes of this Agreement, notices, demands
and all other communications provided for in this Agreement shall be in writing
and shall be deemed to have been duly given when personally delivered when
transmitted by telecopy with

                                      -25-
<PAGE>   7

written confirmation of transmission and receipt, three (3) days after deposit
in the U.S. mail, first class, with adequate postage thereon, or one (1) day
after delivery to an overnight air courier guaranteeing next day delivery,
addressed as follows:

<TABLE>

         <S>                       <C>
         If to the Executive:               Geoffrey L. Faux

         If to the Company:                 eMD.com
                                            5655 Peachtree Parkway
                                            Norcross, Georgia 30092
                                            Attention: Chief Executive Officer

         With a copy to:            Schreeder, Wheeler & Flint, LLP
                                            1600 Candler Building
                                            127 Peachtree Street, N.E.
                                            Atlanta, Georgia 30303-1845
                                            Attention:  Edward H. Brown, Esq.
</TABLE>

or to such other address as any party may have furnished to the others in
writing in accordance herewith, except that notices of change of address shall
be effective only upon receipt as provided above.

         11.      Severability. The invalidity or unenforceability of any
provision or provisions of this Agreement shall not affect the validity or
enforceability of any other provision of this Agreement, which shall remain in
full force and effect; provided, however, that if any one or more of the terms
contained in Sections 5(e), 7 or 8 hereto shall for any reason be held by any
court of competent jurisdiction to be unenforceable by reason of extending for
too great a period of time or over too great a geographical area, by reason of
being too restrictive or expansive, or by constituting an unlawful restraint of
trade in any other respect, then such covenant shall not be deleted but shall be
reformed and constructed in a manner to enable it to be enforced to the extent
compatible with applicable law.

         12.      Assignment. This Agreement may not be assigned by the
Executive, but may be assigned by the Company to any successor to its business
and will inure to the benefit and be binding upon any such successor.

         13       Counterparts. This Agreement may be executed in several
counterparts, each of which shall be deemed to be an original but all of which
together will constitute one and the same instrument.

         14.      Headings. The headings contained herein are for reference
purposes only and shall not in any way affect the meaning or interpretation of
this Agreement.

         15.      Choice of Law. This Agreement shall be construed, interpreted
and the rights of the parties determined in accordance with the laws of the
State of Georgia (without reference to the choice of law provisions of Georgia),
except with respect to matters of law concerning the internal corporate affairs
of any corporate entity which is a party to or the subject of this Agreement,
and as to those matters the law of the jurisdiction under which the respective
entity derives its powers shall govern.

         16.      Dispute Resolution. Absent any irreparable injury being
suffered by the Company entitling the Company to seek injunctive relief against
the Executive pursuant to Section 9 hereof, in the event there shall be a
dispute among the parties arising out of or relating to this Agreement, or the
breach thereof, the parties agree to the following procedures:

                  (a)      Within thirty days after notice from a party of any
         dispute, the parties shall meet and attempt to resolve such dispute
         informally with or without a mediator as the parties mutually agree;

                                      -26-
<PAGE>   8

                  (b)      If the parties are unable to resolve the dispute
         informally, then either party may institute a lawsuit in the federal or
         state courts in Gwinnett County, Georgia. The parties agree that the
         federal and state courts of Gwinnett County, Georgia shall have sole
         jurisdiction over such disputes and each parties expressly consents to
         the personal jurisdiction of such courts and expressly waives all
         defenses of lack of personal jurisdiction and inconvenient forum.

         17.      Entire Agreement. This Agreement contains the entire agreement
and understanding between the Company and the Executive with respect to the
employment of the Executive by the Company as contemplated hereby, and no
representations, promises, agreements or understandings, written or oral, not
herein contained shall be of any force or effect. This Agreement shall not be
changed unless in writing and signed by both the Executive and the Board of the
Company.

         18.      Board Approval. In any case in which this Agreement provides
for the approval, review or determination of the Board in connection with the
Executive's compensation, benefits, termination or compliance with restrictive
covenants herein expressed, then such approval, review or determination shall be
deemed a "Director's conflicting interest transaction", subject to the
procedures required by O.C.G.A. ss. 14-2-860 et seq.

         19.      The Executive's Acknowledgment. The Executive acknowledges he
has had the opportunity to consult with independent counsel of his own choice
concerning this Agreement, and he has read and understands the Agreement, is
fully aware of its legal effect, and has entered into it freely based on his own
judgment.

         IN WITNESS WHEREOF, the parties have executed this Employment Agreement
as of the date and year first above written.

<TABLE>
<CAPTION>
EMD.COM

<S>                                                <C>
By: /s/ Timothy C. Moses
    ---------------------------------

Title:                                             Date:
       ------------------------------                    ----------------------

EXECUTIVE

/s/ Geoffrey L. Faux
-------------------------------------
Geoffrey L. Faux                                   Date:
                                                         -----------------------

-------------------------------------              Date:
Witness                                                  -----------------------
</TABLE><PAGE>   1
                                                                   EXHIBIT 10.13

                            ASSET PURCHASE AGREEMENT

                  AGREEMENT made as of this 25th day of April, 2000, by and
among LABAMERICA, INC., a Georgia corporation with a principal place of business
at 5579 Chamblee-Dunwoody Road, Suite 143, Dunwoody, Georgia 30338 (the
"Company"),GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT, BYRON M.G. SANFORD,
AND RICHARD FISHER (collectively, the "Shareholders") and EMD ACQUISITION CORP.,
a Delaware corporation having an office at 5655 Peachtree Parkway, Norcross,
Georgia 30092("Buyer").

                              W I T N E S S E T H:

         WHEREAS, Shareholders directly own 100% of the capital stock of the
Company;

         WHEREAS, the Company desires to sell and the Buyer desires to purchase
substantially all of the assets of the Company as a going concern which is
presently doing business under the trade names of "LabAmerica" and
"LabAmerica.com."

         NOW THEREFORE, in consideration of the mutual covenants and promises
contained in this Agreement, and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged by all parties, the
parties hereto agree as follows:

                                    ARTICLE I

                PURCHASE AND SALE; REPRESENTATIONS AND WARRANTIES

                  SECTION 1. PURCHASE AND SALE. Subject to the terms and
conditions of this Agreement, the Company hereby sells, assigns and transfers to
the Buyer and the Buyer hereby purchases and acquires from the Company, all of
the right, title and interest of the Company in and to the Purchased Assets (as
hereinafter defined) for a purchase price, which includes (i) $200,000 (the
"Cash Purchase Price"), (ii) 60,000 shares of the common stock of Electronic
Medical Distribution, Inc. ("Parent"), par value $0.0001 per share (the "Buyer
Shares"), and (iii) certain revenue earn out warrants (the "Warrants") as set
forth in Exhibit A (the "Purchase Price") and for the Assumption of the Assumed
Liabilities (herein defined). The parties hereto agree to allocate the Purchase
Price (and all other capital costs) among the Purchased Assets for all purposes
(including financial accounting and tax purposes) in accordance with the
allocation schedule attached hereto as Exhibit A. For purposes of this
Agreement, "Business" shall mean the lab testing business conducted by the
Company under the trade names of "LabAmerica," "LabAmerica.com" and "LabAnon."

         SECTION 2. REPRESENTATIONS OF THE COMPANY AND SHAREHOLDERS. The
following agreements, representations and warranties are made by the Company and
the Shareholders to the Buyer.

<PAGE>   2

                  (A) Corporate Matters; No Conflict. The Company is duly
         organized and validly existing under the laws of the State of Georgia.
         The Company maintains offices only at the site(s) listed on Exhibit A
         and has no operations other than from those site(s). The Company does
         not transact business related to the Business in any other
         jurisdiction. The Company has the corporate power to enter into this
         Agreement, to perform its obligations hereunder and to conduct its
         business as currently conducted. The execution, delivery and
         performance of this Agreement and the transactions contemplated hereby
         by the Company will not (i) conflict with or violate the provisions of
         any applicable law (including, without limitation, any bulk sales
         laws), rule or order, Articles or Certificate of Incorporation, by-laws
         or any other organizational or governing documents of the Company, (ii)
         conflict with or constitute a default under any agreement or contract
         by which the Company is bound or (iii) require the consent or approval
         of, or filing with, any governmental body or third party except as set
         forth on Exhibit C-5. The execution, delivery and performance by the
         Company of this Agreement has been duly authorized and approved by all
         requisite corporate action on the part of the Company and the
         Shareholders. Set forth on Exhibit B is a list of officers, directors,
         and shareholders of the Company, all trade names used by the Business
         and all jurisdictions in is which the Business conducted. This
         Agreement and the consummation of the transactions contemplated hereby
         have been approved by the board of directors of the Company, and the
         authorized officers of the Company named on Exhibit A are authorized
         and empowered by the Company to execute and deliver this Agreement in
         the name and on behalf of the Company.

                  (B)      Purchased Assets.

                           (i) All vendor and customer contracts,
                  confidentiality agreements, purchase and sales orders and
                  other agreements to which the Company is a party and which
                  relate in any manner to the Business and/or the relationship
                  between the Company and the Customers (hereinafter defined),
                  whether written or oral, shall be referred to herein
                  collectively as the "Business Agreements". The Company has
                  delivered to Buyer, on or before the Closing Date, true and
                  correct copies of all Business Agreements Attached hereto as
                  Exhibit C-1 are true and correct copies of the agreements
                  which have been entered into between the Company and its
                  Customers concerning the Business. Also attached as part of
                  Exhibit C-1 is a schedule stating the identity of the Customer
                  to each of those agreements which are in force and effect as
                  of the Closing Date, together with a designation of which form
                  of agreement each such Customer has entered into. Annexed as
                  Exhibit C-2 is a copy of all Business Agreements between the
                  Company and vendors or service providers, or which relate to
                  any strategic partnerships, reselling arrangements or joint
                  ventures between the Company and others, concerning the
                  Business. Listed on Exhibit C-3 is a description of each
                  equipment and personal property lease (collectively, the
                  "Leases") to which the Company is a party and which relates to
                  the Business. The Leases are also included within the
                  definition of Business Agreements as said term is used herein.
                  The Company does not own, lease or use any real estate in
                  connection with the Business except the office and data
                  facilities located at the Sites. Neither the Company nor, to
                  the knowledge of the Company or the Shareholders, any other
                  party, is in default under any Business Agreement and no other
                  party to any

                                       2
<PAGE>   3

                  Business Agreement has made any claim or given the Company
                  notice of any dispute under any Business Agreement, except as
                  set forth on Exhibit C-4. Each Business Agreement is in full
                  force and effect and the Company has the right to assign the
                  Business Agreements to the Buyer and its affiliates and the
                  Company has obtained all required consents to the assignment
                  and transfer thereof, except as set forth on Exhibit C-5. The
                  Company is not the owner or lessee of any motor vehicles which
                  are used in the Business. The Company does not own or lease
                  any interest in any property or any equipment used in the
                  Business, except as expressly stated on Exhibit C-3.

                           (ii) All of the tangible assets of the Company used
                  in the Business, including, without limitation, all machinery,
                  office and other equipment, furniture, computers and related
                  equipment, business machines, telephone systems, parts and
                  accessories, e-mail addresses and Internet domain addresses
                  presently utilized by the Company in the Business, shall be
                  referred to herein collectively as the "Tangible Assets".
                  Attached hereto as Exhibit E is a true and correct list or
                  description of the Tangible Assets. As of the Closing Date,
                  each of the Tangible Assets is in good and operable condition,
                  reasonable wear and tear excepted.

                           (iii) All patents, trademarks, trade names, service
                  marks, service names, logos, designs, formulations, copyrights
                  and other trade rights and all registrations and applications
                  therefor, all know-how, trade secrets, technology or
                  processes, and all computer programs, data bases and software
                  documentation owned or used by the Company in the Business,
                  other than off-the-shelf software licensed by the Company,
                  shall be referred to herein collectively as the "Intellectual
                  Property". Attached hereto as Exhibit F is a true and correct
                  copy of all of the Intellectual Property. Such exhibit also
                  indicates which of such items have been patented or registered
                  or are in the process of application for same. The Company is
                  not infringing on the rights of any third parties to
                  Intellectual Property used, but not owned by, the Company. The
                  Company has valid and fully-paid licenses for all
                  off-the-shelf software used by the Company in its operation of
                  the Business. Included among the Intellectual Property, among
                  other things, are all trade names utilized by the Company in
                  the Business, including, but not limited to, those trade names
                  listed on Exhibit B. On the Closing Date, the Company will
                  deliver to Buyer written proof in form and substance
                  satisfactory to Buyer and its counsel that the Company will no
                  longer do business under any of the trade or domain names
                  listed on Exhibit B and further, within five (5) days of
                  Closing, Company will cause to be filed in all applicable
                  governmental or quasi-governmental offices, any required
                  instruments to terminate any previously filed assumed name or
                  similar certificates regarding such trade names. Promptly
                  after such filing, the Company will deliver proof of said
                  filing to Buyer.

                           (iv) The Company will deliver at the Closing a true
                  and complete copy of the Company's customer list as of the
                  Closing Date relating to the Business which includes, in the
                  case of each customer, the name of the customer, its billing
                  and domain addresses, identity and contact information of each
                  relevant contact person, a statement of the monthly or annual
                  (as indicated) service charges relating to such customer and
                  the Company's files regarding such Customer (the

                                       3
<PAGE>   4

                  "Customer List"). All customers of the Company relating to the
                  Business, including without limitation, those customers
                  included on the Customer List, together with the good will and
                  business opportunities of the Company as it relates to the
                  Business shall be referred to herein as the "Customers."

                           (v) As used herein, the term "Purchased Assets" shall
                  be defined as all classes of assets of the Company as shown on
                  the Company's financial statement as of April 25, 2000
                  (annexed as Exhibit H) utilized by the Company to operate and
                  maintain the Business, including, without limitation, the
                  Business Agreements, the Tangible Assets, the Intellectual
                  Property, the Customer List, the Customers and all other
                  assets of the Company used in connection with the operation of
                  the Business, wherever located, tangible or intangible,
                  excluding, however, Excluded Assets (as defined below). The
                  Purchased Assets are not subject to (i) any lien or
                  encumbrance of any character whatsoever except as set forth on
                  Exhibit M or (ii) any adverse claims by any third parties. At
                  the Closing upon consummation of the transactions contemplated
                  by this Agreement, Buyer will receive good and marketable
                  title to the Purchased Assets, free and clear of all liens,
                  claims and encumbrances of any character whatsoever, except as
                  set forth on Exhibit M. The Purchased Assets include all
                  rights, properties, interests and assets used by Company
                  and/or necessary to permit Buyer to carry on the Business as
                  presently conducted by the Company except for Excluded Assets.

                           (vi) The Company and the Shareholders reasonably
                  expect that the business represented by the Business
                  Agreements will continue after the date hereof. Neither the
                  Company nor the Shareholders have no any knowledge that any
                  customers included on the Customer List, other than those
                  listed on Exhibit G-1, intend to terminate their relationship
                  with the Company or significantly reduce the amount of
                  business they presently do with the Company.

                           (vii) Excluded Assets. The Company is not selling and
                  Purchaser is not buying or acquiring hereunder the following
                  items ("Excluded Assets") which are not included in the
                  defined term "Purchased Assets" which assets are listed on
                  Exhibit L hereto.

                  (C) Financial Statements. The Company has delivered to the
         Buyer copies of the Company's financial statements for the fiscal year
         of the Company ended December 31, 1999. Attached hereto as Exhibit H
         are unaudited financial statements for the quarter ending March 31,
         2000 which reflect the assets, liabilities, net worth, profit and loss,
         and cash flow of the Company with respect to the Business. All
         financial statements referred to herein are complete and correct in all
         material respects, present fairly the financial condition and results
         of operations of the Company as at the dates of such statements and
         have been prepared in accordance with generally accepted accounting
         principles. The books of account and records of the Company have been
         maintained in accordance with good business practice and reflect fairly
         all properties, assets, liabilities and transactions of the Company.
         The Company has no material liabilities or obligations of any kind
         (whether accrued, absolute, direct, indirect, contingent or otherwise)
         which are not fully accrued or reserved against in the Company's
         financial statements in accordance with generally accepted accounting
         principles. Except as set forth on Exhibit I the Company

                                       4
<PAGE>   5

         has no bad debts as of the Closing Date. Since the last day of the
         Company's last fiscal year, the Company has conducted the Business only
         in the ordinary and usual course and has not experienced any material
         adverse change in the Business or the financial condition of the
         Company. Since March 31, 2000, the Company has had no loss in net
         monthly recurring revenue from the Business. Between April 30, 2000 and
         the Closing Date, the Company has not withdraw, expend or applied any
         cash or other assets of the Company, except in the ordinary course of
         operations of the Business of the Company in accordance with past
         practices of the Company, and that during such period no amounts have
         been paid to any officer, director or shareholder except for salaries.
         The books and records of the Company with respect to the Business
         relating to the fiscal year of the Business ending December 31, 1999,
         are adequate to permit an audit of the Business at and for the fiscal
         years then ended.

                  (D) Assumed Liabilities. The Buyer shall not be liable for and
         is not assuming any liabilities of the Company whatsoever, whether
         related or unrelated to the Purchased Assets, or whether arising under
         the Business Agreement or otherwise except as specifically listed on
         Exhibit J hereto (the "Assumed Liabilities"). The Company has no
         outstanding loans, borrowings, guarantees, or debt of any kind with
         respect to the Business and none of the Company's obligations have been
         guaranteed by any other person or entity.

                  (E) Existing Employment Arrangements. Except as set forth on
         Exhibit K the Company has no employment agreements, labor or collective
         bargaining agreements or employee benefit or welfare plans or
         retirement plans. All vacation pay, if any, due to employees of the
         Company who are employed in the Business has been fully paid by the
         Company, except as set forth on Exhibit K. No employees of the Company
         who are employed in the Business are entitled to any sick pay, except
         as set forth on Exhibit K. All vacation pay and sick pay due to
         employees of the Company who are employed in the Business and
         terminated by the Company in connection with the transactions
         contemplated by this Agreement shall be paid in full prior to the
         Closing Date. There are no pending or, to the knowledge of the Company,
         threatened strikes, job actions or other labor disputes affecting the
         Company or its employees and there have been no such disputes for the
         past three years. Also set forth on Exhibit K is a true and complete
         list of all employees of the Company employed in connection with the
         Business, which list provides, among other things, the name, residence
         address, title, job description and salary information concerning each
         employee.

                  (F) Claims, Litigation, Disclosure. There is no claim,
         litigation, tax audit, proceeding or investigation pending or, to the
         Company's knowledge, threatened against the Company, with respect to
         the Business or any of the Purchased Assets of the Company (including,
         any claims of infringement or actions of opposition with respect to
         Intellectual Property), nor does the Company know of any facts which
         would provide a basis for any such claim, litigation, audit, proceeding
         or investigation.

                  (G) Taxes. Except as specifically set forth on Exhibit I (the
         "Tax Liabilities"), the Company has correctly prepared and timely filed
         all Federal, state and local tax returns, estimates and reports, and
         paid all such taxes as and when due. For purposes of this paragraph,
         taxes shall mean all taxes, charges, fees, levies or other assessments
         of

                                       5
<PAGE>   6

         any kind whatsoever (including, without limitation, income, franchise,
         sales, use and withholding taxes). The Company is not a party to any
         tax sharing agreement.

                  (H) No Other Agreements to Sell Assets or Business. The
         Company is not a party to any existing agreement which obligates the
         Company to sell to any other person or firm the Purchased Assets (other
         than sales in the ordinary course of business), to issue or sell any
         capital stock or any security convertible into or exchangeable for
         capital stock of the Company or to effect any merger, consolidation or
         other reorganization of the Company or to enter into any agreement with
         respect thereto.

                  (I) No Brokers. The only broker, leasing agent, finder or
         similar person or entity with whom the Company has made contact or had
         any dealings with or entered into any agreement, arrangement or
         understanding with concerning this Agreement and to whom the Company is
         responsible to pay a finder's fee, brokerage commission or similar
         payment in connection with the transactions contemplated by this
         Agreement is the party or parties listed in item 4 on Exhibit A, if
         any, and the Company shall be solely responsible for the payment of any
         such fee, commission or payment.

                  (J)      Environmental Compliance.

                           (i) Neither the Company nor any operator of the
                  Company's properties is in violation, or alleged to be in
                  violation, of any federal, state or local judgment, decree,
                  order, consent agreement, law (including common law), license,
                  rule or regulation pertaining to environmental health or
                  safety matters, including without limitation those arising
                  under the Resource Conservation and Recovery Act, as amended,
                  the Comprehensive Environmental Response, Compensation and
                  Liability Act of 1980, as amended ("CERCLA"), the Superfund
                  Amendments and Reauthorization Act of 1986, as amended, Water
                  Act, as amended, the Federal Clean Air Act, as amended, the
                  Toxic Substances Control Act, or any state or local analogue
                  (hereinafter "Environmental Laws").

                           (ii) The Company has not received a notice,
                  complaint, order, directive, claim or citation from any third
                  party, including without limitation any federal, state or
                  local governmental authority, indicating or alleging that the
                  Company or any predecessor may have any liability or
                  obligation under any Environmental Law.

                           (iii) (A) No portion of the property of the Company
                  has been used by any person for the generation, handling,
                  processing, treatment, storage or disposal of Hazardous
                  Materials except in accordance with applicable Environmental
                  Laws; (B) no underground tank or other underground storage
                  receptacle for Hazardous Materials, asbestos-containing
                  materials or polychlorinated biphenyls are located on any
                  portion of any location occupied by the Company each of which
                  is listed as a Site on Exhibit A; (C) in the course of any
                  activities conducted by the Company or its invitees, agents,
                  contractors, licensees or employees in connection with the
                  Business of the Company, no Hazardous Materials have been
                  generated or are being used except in accordance with
                  applicable Environmental Laws; and (D) there have been no
                  releases (i.e., any past or present releasing,

                                       6
<PAGE>   7

                  spilling, leaking, leaching, pumping, pouring, emitting,
                  emptying, discharging, injecting, escaping, disposing or
                  dumping) or threatened releases of Hazardous Materials on,
                  upon, into or from the property currently or formerly owned,
                  operated or leased by the Company, which releases would have a
                  material adverse effect on the value of any of the property or
                  adjacent properties or the environment.

                           (iv) The execution, delivery and performance of this
                  Agreement is not subject to any Environmental Laws which
                  condition, restrict or prohibit the sale, lease or other
                  transfer of property or operations, including, without
                  limitation, any so-called "environmental cleanup
                  responsibility acts" or requirements for the transfer of
                  permits, approvals, or licenses. There have been no
                  environmentally related audits, studies, reports, analyses
                  (including soil and groundwater analyses), or investigations
                  of any kind performed with respect to the currently or
                  previously owned, leased, or operated properties of the
                  Company.

                           For purposes of this Section, "Hazardous Material"
                  shall mean any hazardous waste, as defined by 42 U.S.C. ss.
                  6903(5), any hazardous substances or wastes as defined by 42
                  U.S.C. ss. 9601(14), any pollutant or contaminant as defined
                  by 42 U.S.C. ss. 9601(33) or any toxic substances or wastes,
                  oil or hazardous materials or other chemicals or substances
                  regulated by any public or governmental authority.

                  (K) Year 2000. All information technology included in the
         Purchased Assets including, without limitation, in all products and
         services (i) provided by the Business, whether to third parties or for
         internal use or (ii) to the best of the Company's knowledge after
         reasonable investigation, used in combination with any information
         technology of its clients, customers, suppliers or vendors, accurately
         processes or will process date and time data (including, but not
         limited to, calculating, comparing, and sequencing) from, into and
         between the years 1999 and 2000 and the twentieth century and the
         twenty-first century, including leap year calculations and neither
         performance nor functionality of such technology will be affected by
         dates prior to, during and after the year 2000. The Purchased Assets do
         not include any obligations under warranty agreements, service
         agreements or otherwise to remedy any information technology defect
         relating to the year 2000.

                  (L) Licenses and Compliance with Laws. The Company and the
         Shareholders hold governmental or regulatory licenses, permits,
         consents or approvals in connection with the Business as described on
         Exhibit B. The Company is not in violation of any applicable law or
         regulation, or of any judgment, order, decree or other requirement of
         any court, tribunal or governmental body, or any agency or official
         acting in an official capacity, the violation of which, individually or
         in the aggregate, has or might reasonably be expected to have an
         adverse effect on the condition (financial or otherwise), results of
         operations, properties, assets, liabilities, business, or prospects of
         the Company. Without limiting the generality of the foregoing, the
         Company has always been and is currently in compliance with (i) all
         applicable rules and regulations (state or federal) governing
         reimbursement of health care costs under the federal Medicare system
         and all applicable similar state, local or other health care
         reimbursement systems including, without limitation, Medicaid and
         Champus programs, including, without limitation, the Stark

                                       7
<PAGE>   8

         Law, the Medicare and Medicaid anti-kickback rules (42 U.S.C. "1320-7a
         and 1320-7b and all regulations pertaining thereto), the Medicare and
         Medicaid charge limitations and anti-discrimination rules (42 C.F.R.
         405.501-405.515, and 42 C.F.R. 447.300 et seq.), and regulations
         governing Medicaid and Medicare participation by clinical laboratories
         (42 C.F.R. 493.1 et seq.), and (ii) all applicable laws and regulations
         pertaining to the operation of clinical laboratories, including without
         limitation the federal Clinical Laboratories Improvements Act and
         regulations pertaining thereto (42 U.S.C. 263a and 42 C.F.R. "1701 et
         seq.), the Georgia clinical laboratory laws and the Occupational Health
         and Safety Administration=s rules regarding blood borne pathogens (29
         C.F.R. "1910.1030 et seq.), except to the extent that any such
         violations referred to in clauses (i) and (ii) above, individually or
         in the aggregate, has not had and would not reasonably be expected to
         have an adverse effect on the condition (financial or otherwise),
         results of operations, properties, assets, liabilities, business, or
         prospects of the Company.

                  (M) Investment. The Shareholders (i) understand that none of
         the Buyer Shares, the Warrants nor the common stock of Parent issuable
         pursuant to exercise thereto (collectively the "Securities") have not
         been, and will not be, registered under the Securities Act of 1933, or
         under any state securities laws, and are being offered and sold in
         reliance upon federal and state exemptions for transactions not
         involving any public offering, (ii) is acquiring the Securities solely
         for its own account for investment purposes, and not with a view to the
         distribution thereof, (iii) is a sophisticated investor with knowledge
         and experience in business and financial matters, (iv) has received
         certain information concerning the Buyer, Parent, and BioShield
         Technologies, Inc. and has had the opportunity to obtain additional
         information as desired in order to evaluate the merits and the risks
         inherent in holding the Securities, and (v) is able to bear the
         economic risk and lack of liquidity inherent in holding the Securities.

                  (O) True and Complete. No representation or warranty made by
         Company or the Shareholders in this Agreement, nor any statement,
         certificate or exhibit furnished by or on behalf of Company or the
         Shareholders pursuant to this Agreement, nor any document or
         certificate delivered to Buyer pursuant to this Agreement, or in
         connection with the transactions contemplated hereby, contains any
         untrue statement of a material fact, or omits or shall omit to state a
         material fact necessary to make the statements contained therein not
         misleading. The Company and the Shareholders have not failed to
         disclose to Buyer any pending developments or circumstances of which it
         is aware which are reasonably likely to have a material adverse effect
         on the Business.

         SECTION 3. REPRESENTATIONS OF THE BUYER. Buyer represents and warrants
to the Company as follows.

                  (A) Corporate Matters; No Conflict. Buyer is a wholly owned
subsidiary of Parent. Each of the Buyer and Parent is duly incorporated, validly
existing and in good standing under the laws of the State of Delaware, is in
good standing in each other jurisdiction in which it is doing business, except
where failure to be in good standing would not have a material adverse effect on
the business of Buyer or Parent, and has the corporate power to enter into this
Agreement, to perform its obligations hereunder and to conduct its business as
currently conducted. The execution, delivery and performance of this Agreement
and the transactions contemplated hereby (and thereby) by the Buyer and Parent,
respectively, will not (a) conflict

                                       8
<PAGE>   9

with or violate the provisions of any applicable law, rule or order or the
Buyer's or the Parent's respective Certificate of Incorporation or by-laws, (b)
conflict with or constitute a default under any agreement or contract by which
the Buyer or Parent is bound or (c) require the consent or approval of, or
filing with, any governmental body or third party. The execution, delivery and
performance by the Buyer of this Agreement has been authorized and approved by
all requisite corporate action on the part of the Buyer.

         (B) No Brokers. The only broker, leasing agent, finder or similar
person or entity with whom the Buyer or Parent has made contact or had any
dealings with or entered into any agreement, arrangement or understanding with
concerning this Agreement and to whom the Buyer and/or the Parent is responsible
to pay a finder's fee, brokerage commission or similar payment to is the party
listed in item 5 on Exhibit A, if any, and Buyer shall be responsible for the
payment of any such fee, commission or payment.

                                   ARTICLE II

                              PRECLOSING CONDITIONS

         SECTION 1.        GENERAL. Each of the parties will use their best
efforts to take all action and to do all things necessary, proper and advisable
in order to consummate and make effective the transactions contemplated by this
Agreement.

         SECTION 2.        NOTICES AND CONSENTS. The Company and the
Shareholders will give all notices to third parties, and the Shareholders and
the Company will use their best efforts to obtain all third party consents or
approvals necessary to consummate the transactions contemplated by this
Agreement. The Company and the Shareholders will give any notices to, make any
filings with, and use its reasonable best efforts to obtain any necessary
authorizations, consents, and approvals of governments and governmental
agencies.

         SECTION 3.        OPERATION OF BUSINESS. The Company will not engage in
any practice, take any action, or enter into any transaction outside the
ordinary and usual course of business through the Closing or the termination of
this Agreement in substantially the same manner as such business has been
conducted prior to the Closing. Without limiting the generality of the
foregoing, the Company will not (i) except in connection with the consummation
of the transactions contemplated hereby, declare, set aside, or pay any dividend
or make any distribution with respect to its capital stock or redeem, purchase,
or otherwise acquire any of its capital stock, (ii) create or incur any
obligation or liability which would constitute one of the Assumed Liabilities if
in existence as of the Closing except in the ordinary course of business, or
(iii) issue any capital stock or securities, options warrants or other
instruments convertible into the Company's securities, (iv) incur any
indebtedness or make any capital expenditure or guarantee any indebtedness in
excess of $20,000.

         SECTION 4.        PRESERVATION OF BUSINESS. Through the earlier of the
termination of this Agreement of the Closing, the Company will preserve its
business and assets substantially intact, including its present operations,
physical facilities, working conditions, and relationships with lessors,
licensors, suppliers, customers, and employees.

                                       9
<PAGE>   10

         SECTION 5.        FULL ACCESS. The Company will permit representatives
of the Buyer to have full access at all reasonable times, and in a manner so as
not to interfere with the normal business operations of the Company, to all
premises, properties, personnel, books, records (including tax records),
contracts, and documents of or pertaining to the Company.

         SECTION 6.        NOTICE OF DEVELOPMENTS. Each party will give prompt
written notice to the other party of any material adverse development causing a
breach of any of its own representations and warranties set forth herein. No
disclosure by any Party pursuant to this Section 6, however, shall be deemed to
amend or supplement the Exhibits or to prevent or cure any misrepresentation,
breach of warranty, or breach of covenant. If any event, condition, fact or
circumstance that is required to be disclosed under this Section 6 requires any
change in the Exhibits or such event, condition, fact, or circumstance would
require a change in the Exhibits assuming the Exhibits were dated as of such
change, then the Company and the Shareholders shall promptly deliver an update
to the Exhibits specifying such change.

         SECTION 7.        EXCLUSIVITY. So long as this Agreement remains in
effect, neither the Company nor the Shareholders will (i) solicit, initiate, or
encourage the submission of any proposal or offer from any person or entity
relating to the acquisition of any capital stock or other voting securities, or
all or any portion of the assets of the Company whether such acquisition is
structured as a merger, consolidation, or share exchange or asset purchase or
(ii) participate in any discussions or negotiations regarding, furnish any
information with respect to, assist or participate in, or facilitate in any
other manner any effort or attempt by any person or entity to do or seek any of
the foregoing.

         SECTION 8.        BUYER'S LICENSE TO TARGET'S INTELLECTUAL PROPERTY. So
long as this Agreement remains in effect Buyer shall have a nonexclusive license
to use and an exclusive license to market, sell and license the use of any and
all of the Intellectual Property of Company. The sale or licensing of the
Company=s Intellectual Property may be conducted by Buyer in its own name or in
the name of the Company, but all contracts, licenses and revenue from the sale
or licensing of such Intellectual Property by Buyer shall be and remain the
property of the Company prior to the Closing.

         SECTION 9.        PAYMENT OF INDEBTEDNESS BY RELATED PARTIES. The
Company and the Shareholders shall cause all indebtedness and other liability of
each Shareholder, officer, director, and employee and each of their affiliates
("Related Parties") to be discharged and paid in full to the Closing.

         SECTION 10.       ACCRUED PAY. All vacation pay and sick pay due to
employees of the Company who are employed in the Business and terminated by the
Company in connection with the transactions contemplated by this Agreement shall
be paid in full prior to the Closing Date.

         SECTION 11.       TAX LIABILITY. On or before the Closing Date, the
Company shall pay off and satisfy any of the Tax Liabilities which are then due
and payable or payable with respect to the Purchased Assets for the period
ending on the Closing Date whether or not then due, and provide Buyer with
evidence thereof in form satisfactory to Buyer and its counsel.

                                       10
<PAGE>   11
                                   ARTICLE III

                                 INDEMNIFICATION

         SECTION 1. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; INDEMNIFICATION.

                  (A) The representations and warranties of the parties herein
         contained shall survive the closing of the purchase contemplated by
         this Agreement, notwithstanding any investigation at any time made by
         or on behalf of the other party, provided that any claims for
         indemnification in accordance with Article II, Section 2 below with
         respect to any representation or warranty must be made (and will be
         null and void unless made) on or before April 28, 2002 (except in the
         case of representations contained in Paragraphs (B)(v), (G), (I), (J),
         and (L) of Article I, Section 2 hereof, which must be made within six
         (6) months following the expiration of the applicable statute of
         limitations).

                  (B) The Shareholders and the Company jointly and severally
         hereby agree to indemnify and hold Buyer, Parent, and their respective
         officers, directors, stockholders, affiliates, employees,
         representatives and other agents harmless from and against any and all
         claims, liabilities, losses, damages or injuries, together with costs
         and expenses, including reasonable legal fees, arising out of or
         resulting from (i) any breach, misrepresentation or material omission
         of the representations and warranties made by the Company in this
         Agreement or in any Exhibit hereto or other documents delivered in
         connection herewith, (ii) any breach in any material respect by the
         Company, unless waived in writing by the Buyer, of any covenant or
         agreement contained in or arising out of this Agreement, or any other
         agreement delivered in connection herewith on the Closing Date, (iii)
         the Business conducted by the Company prior to the Closing Date and any
         actions or events associated therewith, (iv) any and all liabilities of
         the Company, other than the Assumed Liabilities, and (v) any failure by
         the Company to comply with any provisions of the bulk sales or similar
         laws of any jurisdiction which are applicable to this Agreement or the
         transactions contemplated hereby.

                  (C) Buyer hereby agrees to indemnify and hold the Company and
         the Shareholders harmless from and against any and all claims,
         liabilities, losses, damages or injuries, together with costs and
         expenses, including reasonable legal fees, arising out of or resulting
         from (i) any breach, misrepresentation or material omission in the
         representations and warranties made by the Buyer in this Agreement,
         (ii) any breach in any material respect by Buyer, unless waived in
         writing by the Company, of any covenant or agreement of Buyer contained
         in or arising out of this Agreement, or (iii) the Business as conducted
         by Buyer, after the Closing Date.

                  (D) Any party claiming a right to indemnification hereunder
         (the "Indemnified Party") shall give the other party from whom
         indemnification is sought (the "Indemnifying Party") prompt written
         notice of any claim, demand, action, suit, proceeding or discovery of
         fact (any of which shall be a "Claim") upon which the Indemnified Party
         intends to base a claim for indemnification under this Article III,
         Section 2, provided, however, that no failure to give such notice shall
         excuse any

                                       11
<PAGE>   12

         Indemnifying Party from any obligation hereunder except to the extent
         the Indemnifying Party is materially prejudiced by such failure. The
         Indemnified Party shall not settle or compromise any Claim by a third
         party without the prior written consent of the Indemnifying Party,
         which will not be unreasonably withheld or delayed, unless suit in
         respect of such Claim shall have been instituted against the
         Indemnified Party and the Indemnifying Party shall not have chosen to
         participate in the defense of such suit after notification thereof if
         the Indemnifying Party is entitled to participate under paragraph (E)
         of this Section.

                  (E) In connection with any Claim resulting from or arising out
         of any claim or legal proceeding by a third party, the Indemnifying
         Party, may, upon written notice to the Indemnified Party within 15 days
         following the Indemnified Party's notice of the Claim, assume the
         defense of any such action with its own counsel and its own expense if
         the Indemnifying Party acknowledges to the Indemnified Party in writing
         its obligation to indemnify the Indemnified Party pursuant to this
         Article III, Section 2 in respect of such Claim; provided, however,
         that such counsel is reasonably acceptable to the Indemnified Party and
         provided, further, that if, in the reasonable opinion of the
         Indemnified Party, for any conflict of interest that may arise between
         the Indemnifying Party and the Indemnified Party, the Indemnified Party
         may retain independent counsel at the expense of the Indemnifying
         Party. If the Indemnifying Party assumes the defense or prosecution of
         any such action or proceeding, it shall take all steps reasonably
         necessary in the defense, prosecution and settlement of such action or
         proceeding. The Indemnifying Party shall not, in the defense or
         prosecution of any such action or proceeding except with the written
         consent of the Indemnified Party, consent to the entry of any judgment
         or enter into any settlement which does not include as an unconditional
         term thereof, a release by the third party of the Indemnified Party
         from all liability in respect of the matter which is the subject of
         such action or proceeding. The Indemnified Party shall cooperate in the
         defense or prosecution of any such action or proceeding; provided that
         the Indemnifying Party shall pay or reimburse the Indemnified Party for
         any actual costs or expenses attributable to such cooperation.

                  (F) The obligations of the Company pursuant to paragraph (B)
         of this Section and the obligations of the Buyer pursuant to paragraph
         (C) of this Section shall, in each case be limited to an aggregate
         amount not in excess of the Purchase Price. Neither the Company nor the
         Buyer shall make any Claim hereunder unless and until the aggregate
         amount of such Claim exceeds $25,000; provided, however, that if the
         aggregate amount of Claims by the Buyer or the Company, respectively,
         exceeds $25,000, the obligations of the Company or the Buyer,
         respectively, hereunder shall be with respect to the entire amount of
         such Claims.

                                       12
<PAGE>   13

                                   ARTICLE IV

                        CONDITIONS TO OBLIGATION TO CLOSE

         SECTION 1. CONDITIONS TO OBLIGATION OF THE BUYER. The obligation of the
Buyer to consummate the transactions to be performed by it in connection with
the Closing shall be absolute and unconditional, provided:

                  (i) the representations and warranties of Shareholders and the
         Company set forth herein shall be true and correct in all material
         respects at and as of the Closing Date;

                  (ii) the Company and the Shareholders shall have performed and
         complied with all of its covenants hereunder in all material respects
         through the Closing;

                  (iii) the Company and Shareholders shall have given all
         notices and procured all of the material third Person consents and
         approvals specified herein;

                  (iv) no action, suit, or proceeding shall be pending before
         any court or quasi-judicial or administrative agency of any federal,
         state, local, or foreign jurisdiction or before any arbitrator wherein,
         by reason of any action or failure to act of the Company or the
         Shareholders, an unfavorable injunction, judgment, order, decree,
         ruling, or charge would (A) prevent consummation of any of the
         transactions contemplated by this Agreement, (B) cause any of the
         transactions contemplated by this Agreement to be rescinded following
         consummation, or (C) affect adversely the right of the Buyer to own the
         Purchased Assets or to operate the any business included as part of the
         Purchased Assets;

                  (v) the Shareholders and the Company shall have delivered to
         the Buyer a certificate to the effect that each of the conditions
         specified above in this ARTICLE IV, Section 1 (i)-(iv) have been
         satisfied in all respects;

                  (vi) the Board of Directors of Parent shall have approved the
transactions described in this Agreement; and

                  (vii) all actions to be taken by the Shareholders in
         connection with consummation of the transactions contemplated hereby
         and all certificates, opinions, instruments, and other documents
         required to effect the transactions contemplated hereby, including, but
         not limited to, those matters identified in Article V, Section 2 are
         reasonably satisfactory in form and substance to the Buyer.

The Buyer may waive any condition specified in this ARTICLE IV, Section 1 if it
executes a writing so stating at or prior to the Closing.

         SECTION 2.        CONDITIONS TO OBLIGATION OF THE SELLERS. The
obligation of the Sellers to consummate the transactions to be performed by it
in connection with the Closing shall be absolute and unconditional, provided:

                                       13
<PAGE>   14

                  (i) the representations and warranties of the Buyer set forth
         herein shall be true and correct in all material respects at and as of
         the Closing Date;

                  (ii) the Buyer shall have performed and complied with all of
         its covenants and agreements hereunder in all material respects through
         the Closing Date;

                  (iii) no action, suit, or proceeding shall be pending before
         any court or quasi-judicial or administrative agency of any federal,
         state, local, or foreign jurisdiction or before any arbitrator wherein
         by reason of any action or failure to act of Buyer, an unfavorable
         injunction, judgment, order, decree, ruling, or charge would (A)
         prevent consummation of any of the transactions contemplated by this
         Agreement or (B) cause any of the transactions contemplated by this
         Agreement to be rescinded following consummation;

                  (iv) the Buyer shall have delivered to the Shareholders a
         certificate to the effect that each of the conditions specified above
         in this ARTICLE IV, Section 2 (i)-(iii) have been satisfied in all
         respects;

The Shareholders may waive any condition specified in this ARTICLE IV, Section 2
if it executes a writing so stating at or prior to the Closing.

                                    ARTICLE V

                        CLOSING AND DELIVERIES AT CLOSING

         SECTION 1. CLOSING. The closing of the purchase and sale of the
transaction contemplated herein shall take place on or about May 3,, 2000 (the
"Closing"), at the offices of Sims Moss Kline & Davis LLP, located at 400
Northpark Town Center, Suite 310, 1000 Abernathy Road, NE, Atlanta, Georgia
30328 at 10:00 a.m. The deliveries described in Section 2 and 3 of this Article
V shall be made at the Closing.

         SECTION 2. DELIVERIES BY THE COMPANY. On the Closing Date, the
Shareholders and the Company will deliver, or cause to be delivered, to the
Buyer the following:

                  (A) Such instruments of transfer or conveyance executed by the
         Company, as Buyer may reasonably request in order to convey and
         transfer to Buyer good and marketable title to all of the Purchased
         Assets, free and clear of all liens, claims, encumbrances and other
         charges, including, without limitation, an Assignment Agreement and a
         Bill of Sale.

                  (B) Physical delivery of all Tangible Assets by making them
         available at the Sites listed on Exhibit A, together with any and all
         warranties, manuals, instructions, and other literature in the
         possession of the Company relating to the ownership or operation of the
         Tangible Assets. In addition, such notices to telephone companies and
         others required to transfer the Company's e-mail addresses and domain
         addresses, used in the Business to Buyer.

                                       14
<PAGE>   15

                  (C) Physical delivery of all original or certified copies of
         documentation concerning the Intellectual Property, including, without
         limitation, registrations and applications of any patents, trademarks
         or service marks, original artwork, data bases, computer programs and
         software.

                  (D) The following corporate documentation:

                           (i) The Company's Articles or Certificate of
                  Incorporation certified as of a date within five (5) days
                  prior to the Closing Date by the Secretary of State of the
                  state of the Company's organization;

                           (ii) The Company's By-Laws certified as of the
                  Closing Date by the President or Secretary of the Company as
                  being in full force and effect and unmodified; and

                           (iii) Corporate Resolutions of the Board of Directors
                  and Shareholders of the Company, approving this Agreement and
                  all the transactions contemplated hereby, certified by the
                  President or Secretary of the Company as being in full force
                  and effect and unmodified.

                  (E) The opinion of counsel to the Company and Shareholders, in
         a form acceptable to Buyer and its counsel.

                  (F) Evidence in form satisfactory to Buyer and its counsel
         that the Tax Liabilities, if any, have been paid off and satisfied.

                  (G) The Noncompetition Agreements for each of the Company and
         the Shareholders, in substantially the form as Exhibit N attached
         hereto.

                  (H) Copies of written proof in form and substance satisfactory
         to Buyer and its counsel that the Company will no longer do business
         under any of the trade and domain names listed on Exhibit B as required
         pursuant to Article I, Section 2, Paragraph (B) (iii) hereof.

                  (I) The Company shall use its best efforts to deliver a
Non-Disclosure and Intellectual Property Agreement in a form to be provided by
Buyer prior to the Closing, executed by each employee of the Company who will be
employed by Buyer or its affiliate immediately following the Closing.

                  (K) Notices of termination of all employees of the Company
         employed in connection with Business satisfactory to Buyer, which
         notices will be delivered to the employees concurrently with the
         Closing.

                  (L) The Employment/Consultant Agreements of David Nelson and
         Gregory Smith, M.D., in substantially the form as Exhibit O attached
         hereto.

                  (M) Such notice or notices as Buyer may reasonably request in
         order to notify the customers included on the Customer List that the
         Business has been sold to Buyer.

                                       15
<PAGE>   16

         SECTION 3.        DELIVERIES BY THE BUYER.

         On the Closing Date, the Buyer will deliver, or cause to be delivered,
to the Company the following:

                  (A) The Cash Purchase Price by cash, or certified or official
         bank check payable to the order of the Company, or by wire transfer of
         federal funds to the account of the Company, as the Company shall
         direct in writing on or before the Closing Date; provided, however,
         Buyer may, upon written agreement of all parties hereto, deduct from
         the Purchase Price and pay directly amounts due any creditor of the
         Company, including, without limitation, the Tax Liabilities (but
         excluding any amounts due for any of the Assumed Liabilities), in which
         event, evidence of such payment shall be presented at the Closing.

                           (B)      The Buyer Shares;

                  (D) Such instruments of assignment and assumption executed by
         the Buyer, as the parties hereto reasonably may determine necessary to
         effectuate the assignment to the Buyer of the Business Agreements and
         the assumption by Buyer of the Assumed Liabilities.

                  (E) Resolution of the Board of Directors of Buyer, authorizing
the execution of this Agreement and the transactions contemplated hereby.

                  (F) The opinion of Sims Moss Kline & Davis LLP, outside
counsel to the Buyer, in a form acceptable to the Company and its counsel.

                                   ARTICLE VI

                          OBLIGATIONS FOLLOWING CLOSING

         SECTION 1. FURTHER COOPERATION. The Company will, at any time and from
time to time after the Closing Date, execute and deliver such further
instruments of conveyance, transfer and license, and take such additional
actions as Buyer, Parent or its successor and/or assigns, may reasonably
request, to effect, consummate, confirm or evidence the transfer to Buyer of the
Purchased Assets pursuant to this Agreement.

         SECTION 2.        TRANSITION ASSISTANCE AND ADJUSTMENTS.

                  (A) The Company shall cooperate and provide assistance to the
         Buyer as shall be reasonably necessary during the transition of the
         Business and the Purchased Assets from the Company to the Buyer, or its
         successors and/or assigns, after the Closing Date.

                  (B) Buyer and its successors and/or assigns shall have the
         right at any time and from time to time upon reasonable notice and
         during normal business hours to

                                       16
<PAGE>   17

         examine and make copies of all corporate books, records and other
         documents of the Company and generated prior to the Closing Date, which
         documents will be maintained by the Company for a period of five (5)
         years after the Closing Date.

                  (C) The Company will reasonably cooperate with Buyer in
         notifying the customers included on the Customer List that the Business
         has been sold to Buyer, including, without limitation, executing any
         additional notices which Buyer may reasonably request. The Company will
         not, directly or indirectly, take any action which is designed or
         intended to have the effect of discouraging customers, suppliers or
         vendors and other business associates of the Business, from maintaining
         the same business relationships with Buyer or its successors and/or
         assigns after the Closing Date as were maintained with the Company with
         respect to the Business prior to the Closing Date.

                  (D) The Buyer shall collect all Closing Accounts Receivable
         following the Closing Date Receivable of the Company. If payment of any
         Closing Account Receivable is received by the Company, it shall
         promptly forward to Buyer the full amount so received for the Buyers
         benefit. The Company will cooperate with Buyer in establishing a bank
         account of Buyer in the name of ["LabAmerica"] in order to facilitate
         the negotiation of checks received from customers of the Company after
         the Closing.

                  (E) All of the Company's right, title and interest in and to
         the name "LabAmerica" constitutes a Purchased Asset and has been
         transferred to the Buyer in accordance with this Agreement. Following
         the Closing, neither the Company nor any affiliate of the Company (as
         defined under federal securities laws), shall not use the name
         "LabAmerica" or any confusingly similar name to said trade name in any
         trade or business. The Company expressly acknowledges, understands and
         agrees (i) that remedies at law for any breach of this Article VI,
         Section 2((E) will be inadequate, (ii) that the damages resulting from
         such breach are not readily susceptible to measurement in monetary
         terms and (iii) that the Buyer shall be entitled to immediate
         injunctive relief and may obtain temporary and permanent orders
         restraining any threatened or further breach of this Article VI,
         Section 2(E) by the Company. The Company has been advised by its
         counsel with respect to the meaning and effect of this Article VI,
         Section 2(E).

                                   ARTICLE VII

                                   TERMINATION

         SECTION 1.        TERMINATION EVENTS. This Agreement may be terminated
prior to the Closing:

                  (i) By the Buyer if (i) there is a material breach of any
         covenant or obligation of the Company or any of the Shareholders, or
         (ii) the Buyer reasonably determines that the timely satisfaction of
         any condition set forth in this Agreement has become impossible or
         impractical (other than as a result of any failure on the part of Buyer
         to comply with or perform its covenants and obligations under this
         Agreement);

                                       17
<PAGE>   18

                  (ii) by the Company if (i) there is a material breach of any
         covenant or obligation of the Buyer or (ii) the Company reasonably
         determines that the timely satisfaction of any condition set forth in
         this Agreement has become impossible or impractical (other than as a
         result of any failure on the part of the Company or any of the
         Shareholders to comply with or perform any covenant or obligation set
         forth in this Agreement);

                  (iii) by the Buyer if the Closing has not taken place on or
         before May31, 2000 (other than as a result of any failure on the part
         of Buyer to comply with or perform its covenants and obligations under
         this Agreement);

                  (iv) by the Company if the Closing has not taken place on or
         May 31, 2000 (other than as a result of the failure on the part of the
         Company or any of the Shareholders to comply with or perform any
         covenant or obligation set forth in this Agreement);

                  (v) by the Buyer if the Company, Shareholders or any of its
         representatives has given Buyer materially false or misleading
         information or representations in writing or failed to disclose in
         writing material information regarding Company;

                  (vi) The Company files a bankruptcy petition or a bankruptcy
         petition is filed against the Company or the Company makes a general
         assignment for the benefit of creditors, and such petition or
         assignment is not removed or terminated within a period of 45 days
         after such filing or assignment;

                  (vii) A receiver or similar official is appointed for the
         Company's business and such appointment is not terminated within a
         period of 45 days after such appointment, or the business is
         terminated; and

                  (viii) Any judgments or arbitration awards are entered against
         Seller, or Seller enters into any settlement agreements with respect to
         any litigation or arbitration, in an aggregate amount of $50,000 or
         more in excess of any insurance coverage therefor; or

                  (ix) by the mutual consent of the Company, Shareholders and
         the Buyer.

         SECTION 2.        TERMINATION PROCEDURES. If Purchaser wishes to
terminate this Agreement pursuant to this ARTICLE VII, Purchaser shall deliver
to Seller a written notice stating that Purchaser is terminating this Agreement
and setting forth a brief description of the basis on which Purchaser is
terminating this Agreement. If Seller wishes to terminate this Agreement
pursuant to ARTICLE VII, Seller shall deliver to Purchaser a written notice
stating that the Agent is terminating this Agreement and setting forth a brief
description of the basis on which Seller is terminating this Agreement. In the
event that the alleged breach is curable, the alleged breaching party shall have
a thirty (30) day period from the date of such written notice to cure any such
breach.

         SECTION 3.        NONEXCLUSIVITY OF TERMINATION RIGHTS. The termination
rights provided in Article VII shall not be deemed to be exclusive. Accordingly,
the exercise by any party of its

                                       18
<PAGE>   19

right to terminate this Agreement pursuant to ARTICLE VII shall not be deemed to
be an election of remedies and shall not be deemed to prejudice, or to
constitute or operate as a waiver of, any other right or remedy that such party
may be entitled to exercise (whether under this Agreement, under any other
agreement, under any statute, rule or other legal requirement, at common law, in
equity or otherwise).

                                  ARTICLE VIII

                                  MISCELLANEOUS

         SECTION 1. GOVERNING LAW; JURISDICTION. This Agreement shall be
governed by the laws of the Georgia.. The parties hereto submit and consent to
the exclusive jurisdiction of the state courts of the State of Georgia in Fulton
County and the federal courts located therein with respect to any legal actions
relating to this Agreement, or any other agreements delivered in connection
herewith, between the Company, on the one hand, and the Buyer , on the other
hand, and any transactions contemplated thereby.

         SECTION 2. COUNTERPARTS. This Agreement may be executed in several
counterparts, each of which shall be an original and all of which together shall
constitute one and the same instrument.

         SECTION 3. CONFIDENTIALITY. The Company, on the one hand, and the
Buyer, on the other hand, each agree not to disclose or use any information
acquired by it about the other party during the course of the negotiations of
this Agreement and the transactions to which it relates which is confidential in
nature or not otherwise generally available to the public without the prior
written consent of such other party unless required to do so by applicable law
or regulation or by order of a court of competent jurisdiction or an
administrative agency. Each party shall be liable for any breach by its
respective employees, officers, directives, shareholders, agents and/or
contractors of the provisions of this Section.

         SECTION 4. AMENDMENTS. This Agreement supersedes any prior contracts
relating to the subject matter hereof between the Buyer, Parent, the
Shareholders and the Company. This Agreement cannot be changed, modified or
amended and no provision or requirement hereof may be waived without the consent
in writing of the parties hereto.

         SECTION 5. SEVERABILITY. The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of
any other provision of this Agreement, which shall remain in full force and
effect. Each provision of this Agreement shall be deemed to be the agreement of
the parties hereto to the full extent that the power to enter into such
provisions shall have been conferred on the parties by law.

         SECTION 6. BENEFIT; ASSIGNMENT. This Agreement is binding upon and
inures to the benefit of the parties, their successors and permitted assigns.
This Agreement may not be assigned or the duties of the parties hereunder
delegated to others without the prior written consent of all parties hereto,
except that Buyer may assign its rights, duties and obligations hereunder to
Parent or an affiliate of Buyer or Parent without the Shareholders' and
Company's consent.

                                       19
<PAGE>   20

         SECTION 7. CONSTRUCTION. All exhibits annexed hereto are hereby
incorporated herein by reference and made a part of this Agreement. Whenever
used in this Agreement and the context so requires, the singular shall include
the plural and the plural shall include the singular.

         SECTION 8. IMPUTED KNOWLEDGE. Any reference in this Agreement to the
"knowledge of" the Company, or words of similar import, the knowledge of any and
all of the officers or directors of the Company (including, without limitation,
its President, Gregory Smith; its executive Vice President, David Nelson; and
Webmaster, Gordon Schuchardt) shall be imputed to be the knowledge of the
Company. Any reference in this Agreement to the "knowledge of" the Buyer, or
words of similar import, the knowledge of its officers and directors (including,
without limitation, Buyer's President, Timothy C. Moses) shall be imputed to be
the knowledge of the Buyer.

                    [SIGNATURES APPEAR ON THE FOLLOWING PAGE]

                                       20
<PAGE>   21

         IN WITNESS WHEREOF, the parties have executed and delivered this
Agreement as of the date first above written.

                              EMD ACQUISITION CORP.

                              By:
                                 ---------------------------------------
                                       Timothy C. Moses, President

                              LABAMERICA, INC.

                              By:
                                 ---------------------------------------
                                       Gregory Smith, President

                              SHAREHOLDERS:

                              -----------------------------------------
                              David Nelson

                              -----------------------------------------
                              Gordon Schuchardt

                              -----------------------------------------
                              Gregory Smith, M.D.

                              -----------------------------------------
                              Byron M.G. Sanford

                              -----------------------------------------
                              Richard Fisher

                                       21
<PAGE>   22

                            DESCRIPTION OF EXHIBITS:

<TABLE>
<S>           <C> <C>
Exhibit A     -   Basic Provisions

Exhibit B     -   Officers; Directors; Trade Names; Jurisdictions, Licenses; Permits

Exhibit C-1   -   Forms of Business Agreements with Customers

Exhibit C-2   -   Copy of all Business Agreements

Exhibit C-3   -   Leases

Exhibit C-4   -   Claims of Disputes Under Business Agreements

Exhibit C-5   -   Consents to Transfer or Assign Not Obtained

Exhibit D     -   Litigation

Exhibit E     -   Tangible Assets

Exhibit F     -   Intellectual Property

Exhibit G     -   Customer List and Related Information

Exhibit G-1   -   Customer Terminations

Exhibit H     -   Financial Statements

Exhibit I     -   Bad Debts and Tax Liabilities of the Company

Exhibit J     -   Assumed Liabilities

Exhibit K     -   Existing Employment Agreements, Labor or Collective Bargaining Agreements,
                  Employee Benefit or Welfare Plans, Retirement Plans, Description of Employees

Exhibit L     -   Excluded Assets

Exhibit M     -   Liens; Encumbrances

Exhibit N     -   Noncompetition Agreements for the Company and the Shareholders

Exhibit O     -   Employment/Consulting Agreements for each of  David Nelson and Gregory Smith, M.D._

Exhibit P     -   Warrant Agreement for each of Shareholders
</TABLE>

                                       22
<PAGE>   23

                                    EXHIBIT A
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

BASIC PROVISIONS

1.       Name of Buyer:    EMD ACQUISITION CORP.

2.       Name of Company:  LABAMERICA, INC.

         (a)      State of Incorporation of Company: Georgia

         (b)      Authorized Officers of the Company:

                  Gregory Smith, M.D., President
                  David Nelson, Secretary
                  Gordon Schuchardt, Treasurer

         (c) Address of each Site from which the Company conducts the Business:

         5579 Chamblee Dunwoody Road, Suite 143; Dunwoody, Georgia  30338

3.       Purchase Price:   $200,000 in cash
                                    60,000 shares of EMD
                                    Performance Warrants attached as Exhibit P

4.       Company's Broker: None

5.       Buyer's Broker: None

6.       Allocation of Purchase Price among Purchase of Assets:
                   As determined by Buyer

<PAGE>   24

                                    EXHIBIT B
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

OFFICERS: Gregory Luke Smith, MD., President; David Nelson, Secretary; Gordon
Schuchardt, Treasurer

DIRECTORS: Gregory Luke Smith, MD., David Nelson, Gordon Schuchardt

SHAREHOLDERS: Gregory Luke Smith, M.D. (353 shares or 35.3 %), David Nelson (303
shares or 30.3%), Gordon Schuchardt (303 shares or 30.3 %), Byron M. G. Sanford,
Esq. (20.5 shares or 2.05%), Richard Fisher, CPA (20.5 shares or 2.05%)

TRADE NAMES: LabAmerica.com (non-registered); LabAmerica (registered with
Network solutions); LabAnon (registered network solutions)

JURISDICTIONS IN WHICH COMPANY IS DOING BUSINESS:  Georgia

GOVERNMENT OR REGULATORY LICENSES, PERMITS, CONSENTS, OR APPROVALS HELD BY THE
COMPANY AND THE SHAREHOLDERS

None

<PAGE>   25

                                   EXHIBIT C-1
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

FORMS OF BUSINESS AGREEMENTS WITH CUSTOMERS

         NONE

PERSONAL PROPERTY LEASES:  None

EQUIPMENT LEASES: None

<PAGE>   26

                                   EXHIBIT C-2
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

COPIES OF ALL BUSINESS AGREEMENTS AND VENDOR/SERVICE PROVIDER AND OTHER
AGREEMENTS:

1.       "Flash Cash" Agreement between LabAmerica and Western Union is annexed
         hereto.

2.       Pricing Agreement between LabAmerica and Quest is annexed hereto.

<PAGE>   27

                                   EXHIBIT C-3
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

LEASES  None

<PAGE>   28

                                   EXHIBIT C-4
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

CLAIMS OF DISPUTES UNDER BUSINESS AGREEMENTS

None

<PAGE>   29

                                   EXHIBIT C-5
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

CONSENTS TO TRANSFER AND ASSIGNMENT NOT OBTAINED

NONE

<PAGE>   30

                                    EXHIBIT E
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

TANGIBLE ASSETS

ALL TANGIBLE AND INTANGIBLE PROPERTY OWNED OR LEASED BY THE COMPANY , INCLUDING,
BUT NOT LIMITED TO, ALL FURNITURE, FIXTURES AND EQUIPMENT, ACCOUNTS RECEIVABLE,
NOTES RECEIVABLE, CONTRACTS, INTELLECTUAL PROPERTY AND THE LIKE.

TELEPHONE NUMBERS:

770-662-5325
--------------------------

FACSIMILE NUMBERS:

1-800-590-9741
--------------------------

INTERNET DOMAIN ADDRESSES:

WWW.LABAMERICA.COM
WWW. LABANON.COM__________________________

<PAGE>   31

                                    EXHIBIT F
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

INTELLECTUAL PROPERTY

 WWW.LABAMERICA.COM
www.labanon.com

<PAGE>   32

                                    EXHIBIT G
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

CUSTOMER LIST AND RELATED INFORMATION

This list will be provided at closing, but is not attached due to the
confidential nature of the Customer list and related information.

<PAGE>   33

                                   EXHIBIT G-1
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

CUSTOMER TERMINATIONS

None terminated

<PAGE>   34

                                    EXHIBIT H
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

FINANCIAL STATEMENTS

ATTACHED HEREWITH

<PAGE>   35

                                    EXHIBIT I
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

BAD DEBTS AND TAX LIABILITIES OF THE COMPANY:

         None - see accountants letters attached

<PAGE>   36

                                    EXHIBIT J
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

ASSUMED LIABILITIES: None

<PAGE>   37

                                    EXHIBIT K
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

EXISTING EMPLOYMENT AGREEMENTS, LABOR OR COLLECTIVE BARGAINING AGREEMENTS AND
EMPLOYEE BENEFIT OR WELFARE PLANS AND RETIREMENT PLANS

None

DESCRIPTION OF EMPLOYEES

Gregory Smith, M.D. - Medical Director
David Nelson - Director of Operations
Gordon Schuchardt - Web Master

<PAGE>   38

                                    EXHIBIT L
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

EXCLUDED ASSETS - None, except accounts or notes payable and all other
indebtedness by or obligations by the Company of any kind or any claims, damages
or liabilities incurred by the Company of any kind prior to the Closing
including, but not limited to taxes of any kind.

<PAGE>   39

                                    EXHIBIT M
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

LIENS; ENCUMBRANCES - None

<PAGE>   40

                                    EXHIBIT N
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

NONCOMPETITION AGREEMENTS

None

<PAGE>   41

                                    EXHIBIT O
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

EMPLOYMENT/CONSULTANT AGREEMENTS FOR EACH OF DAVID NELSON AND  GREGORY SMITH, MD

         SEE ANNEXED

<PAGE>   42

                                    EXHIBIT P
                                       TO
                            ASSET PURCHASE AGREEMENT
                                  BY AND AMONG
                 GREGORY SMITH, DAVID NELSON, GORDON SCHUCHARDT,
                     BYRON M.G. SANFORD, AND RICHARD FISCHER
                                       AND
                              EMD ACQUISITION CORP.
                                       AND
                                LABAMERICA, INC.

WARRANT AGREEMENT FOR EACH OF SHAREHOLDERS:

LABAMERICA SHAREHOLDERS, IN AGGREGATE BASED ON THEIR PRO-RATA RESPECTIVE
OWNERSHIP INTERESTS IN THE COMPANY AS DESCRIBED IN THESE EXHIBITS, ARE ENTITLED
TO RECEIVE WARRANTS TO PURCHASE COMMON STOCK OF PARENT, COMPUTED IN THE
FOLLOWING MANNER:

FIFTEEN PERCENT WARRANT COVERAGE (15%) BASED UPON THE TWELVE (12) MONTHS RETAIL
REVENUES OF LABAMERICA ACTUALLY RECEIVED BY THE COMPANY, BEGINNING MAY 1, 2000.
SUCH WARRANT COVERAGE IS COMPUTED BY MULTIPLYING SUCH DEFINED PERIOD REVENUES BY
15% (.15) AND DIVIDING THE WARRANT COVERAGE AMOUNT BY THE TRADING PRICE OF THE
PARENT'S COMMON STOCK ON APRIL 30, 2001.

TRADING PRICE IS DEFINED AS THE FIVE DAY AVERAGE OF THE CLOSING ASK PRICE OF THE
PARENT'S COMMON STOCK AS TRADED ON A NATIONAL SECURITIES EXCHANGE. IF THE
COMPANY IS NOT SO TRADED PUBLICLY, TRADING PRICE IS DEFINED AS THE MOST RECENT
PRICE THE COMPANY SOLD ITS COMMON STOCK, IN A PRIVATE TRANSACTION, PRIOR TO
APRIL 30, 2001.

THE EXERCISE PRICE FOR SUCH WARRANTS WILL BE THE TRADING PRICE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}]]